This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Medication Request for bresentrik - XML Representation

Raw xml | Download

<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="medicationrequest-for-bresentrik"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="medicationrequest-for-bresentrik"> </a><a name="hcmedicationrequest-for-bresentrik"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest &quot;medicationrequest-for-bresentrik&quot; </p></div><p><b>identifier</b>: <code>http://www.bmc.nl/portal/medstatements</code>/1234568900-studyDrug (use: official)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: <a href="Medication-bresentrik.html">Medication/bresentrik: bresentrik 2mg tablet</a></p><p><b>subject</b>: <a href="Patient-JanetPatient.html">Patient/JanetPatient: Janet</a> &quot; CLINICAL TRIAL PATIENT&quot;</p><p><b>supportingInformation</b>: <a href="ResearchStudy-BreastCancerTrial.html">ResearchStudy/BreastCancerTrial</a></p><p><b>authoredOn</b>: 2023-04-05</p><p><b>requester</b>: <span>: Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD</span></p><p><b>reasonCode</b>: Breast Cancer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#254837009)</span></p><p><b>instantiatesCanonical</b>: <a href="http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy">http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy</a></p><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</p><p><b>timing</b>: Once per 1 days</p><p><b>route</b>: Oral route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote><blockquote><p><b>dispenseRequest</b></p><p><b>numberOfRepeatsAllowed</b>: 1</p><p><b>quantity</b>: 600 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><h3>ExpectedSupplyDurations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Value</b></td><td><b>Unit</b></td><td><b>System</b></td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>30</td><td>days</td><td><a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-ucum.html">Unified Code for Units of Measure (UCUM)</a></td><td>d</td></tr></table></blockquote></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="http://www.bmc.nl/portal/medstatements"/>
    <value value="1234568900-studyDrug"/>
  </identifier>
  <status value="active"/>
  <intent value="order"/>
  <medicationReference>🔗 
    <reference value="Medication/bresentrik"/>
    <display value="bresentrik 2mg tablet"/>
  </medicationReference>
  <subject>🔗 
    <reference value="Patient/JanetPatient"/>
    <display value="Janet"/>
  </subject>
  <supportingInformation>🔗 
    <reference value="ResearchStudy/BreastCancerTrial"/>
  </supportingInformation>
  <authoredOn value="2023-04-05"/>
  <requester>
    <display
             value="Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD"/>
  </requester>
  <reasonCode>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="254837009"/>
      <display value="Breast Cancer"/>
    </coding>
  </reasonCode>
  <instantiatesCanonical
                         value="http://baseUrlOfHospitalHolding/PlanDefinition/protocol-for-the-ResearchStudy"/>
  <dosageInstruction>
    <sequence value="1"/>
    <text
          value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL"/>
    <timing>
      <repeat>
        <frequency value="1"/>
        <period value="1"/>
        <periodUnit value="d"/>
      </repeat>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="26643006"/>
        <display value="Oral route (qualifier value)"/>
      </coding>
    </route>
    <doseAndRate>
      <type>
        <coding>
          <system
                  value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/>
          <code value="ordered"/>
          <display value="Ordered"/>
        </coding>
      </type>
      <doseQuantity>
        <value value="6"/>
        <unit value="mg"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="mg"/>
      </doseQuantity>
    </doseAndRate>
  </dosageInstruction>
  <dispenseRequest>
    <numberOfRepeatsAllowed value="1"/>
    <quantity>
      <value value="600"/>
      <unit value="mg"/>
      <system value="http://unitsofmeasure.org"/>
      <code value="mg"/>
    </quantity>
    <expectedSupplyDuration>
      <value value="30"/>
      <unit value="days"/>
      <system value="http://unitsofmeasure.org"/>
      <code value="d"/>
    </expectedSupplyDuration>
  </dispenseRequest>
</MedicationRequest>